Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03969056 · ClinicalTrials.gov registry record · NA

AI Activity Study in Patients With Elevated Blood Pressure

A NA study, sponsored by University of California, San Francisco.

Terminated
Registry status
NA
Development phase
7
Enrollment target

NCT03969056 is a NA study that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 7 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03969056, a NA study, was terminated before completion, sponsored by University of California, San Francisco.

TERMINATED
Registry status
NA
Development phase
7 participants
Enrollment target

Study Summary

In this pilot RCT, a total of 40 adults with hypertension will be randomized to either an artificial intelligence (AI) physical activity intervention group or an active control group with a 1 to 1 ratio after completing a 2-week run-in period and 4-week training. The AI intervention group will receive an automated and personalized daily step goal intervention involving a sophisticated activity analytics algorithm using advanced statistics and machine learning, while the active control group will receive a standardized and fixed 10,000 daily steps goal. Both groups will receive an identical smartphone app (app content differs between the two groups) and ActiGraph GT9X Link to assess objectively measured physical activity (primary outcome) during the study period.

Interventions

  • BEHAVIORAL 10,000 steps
  • BEHAVIORAL Artificial Intelligence (AI) Activity

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2020-02-06
Est. Completion 2020-04-30
Phase NA

What the Registry Record Tells You About NCT03969056

The ClinicalTrials.gov registry entry for NCT03969056 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which 10,000 steps is the first listed.

NCT03969056 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03969056 about?

NCT03969056 is a clinical study titled "AI Activity Study in Patients With Elevated Blood Pressure". In this pilot RCT, a total of 40 adults with hypertension will be randomized to either an artificial intelligence (AI) physical activity intervention group or an active control group with a 1 to 1 ratio after completing a 2-week run-in period and 4-week training. The AI intervention group will recei...

What is the current status of trial NCT03969056?

This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2020-02-06. Estimated completion is 2020-04-30.

What interventions are being tested in trial NCT03969056?

The interventions under investigation include: 10,000 steps (BEHAVIORAL), Artificial Intelligence (AI) Activity (BEHAVIORAL).

Who is sponsoring clinical trial NCT03969056?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.